Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page
- Check3 days agoChange DetectedFunding-lapse notice regarding government operations was removed from the page; all trial details and links remain unchanged.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedNo significant changes detected; the update appears to involve minor formatting and layout adjustments on the Study Details page without altering core study information (eligibility criteria, endpoints, or enrollment details). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check46 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference2%

- Check53 days agoChange DetectedUpdated version to v3.1.0 and added multiple contact emails and phone numbers; older version reference v3.0.2 was removed.SummaryDifference0.0%

- Check67 days agoChange DetectedShift to Revision: v3.0.2 is now present; the previous v3.0.1 and the Back to Top link were removed. No other substantive content changes were detected.SummaryDifference0.1%

- Check75 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.